These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38950963)

  • 1. HPV: Cameroon fights back against one of the world's lowest vaccination rates.
    Ferguson S
    BMJ; 2024 Jul; 386():q607. PubMed ID: 38950963
    [No Abstract]   [Full Text] [Related]  

  • 2. Population-based HPV vaccination programmes are safe and effective: 2017 update and the impetus for achieving better global coverage.
    Brotherton JML; Bloem PN
    Best Pract Res Clin Obstet Gynaecol; 2018 Feb; 47():42-58. PubMed ID: 28986092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPV vaccination: should it be mandatory for entry into public school?
    Gray JR
    Nurs Womens Health; 2007 Apr; 11(2):133-8. PubMed ID: 17883794
    [No Abstract]   [Full Text] [Related]  

  • 4. [Implementation of HPV vaccination in Germany].
    Schreckenberger C; Kaufmann AM; Schneider A
    Dtsch Med Wochenschr; 2007 Oct; 132(42):2221-4. PubMed ID: 17926251
    [No Abstract]   [Full Text] [Related]  

  • 5. Culturally tailored intervention increases HPV vaccination rates among Asian American adolescents.
    Printz C
    Cancer; 2019 May; 125(10):1583. PubMed ID: 31026074
    [No Abstract]   [Full Text] [Related]  

  • 6. Implementation of a human papillomavirus vaccination demonstration project in Malawi: successes and challenges.
    Msyamboza KP; Mwagomba BM; Valle M; Chiumia H; Phiri T
    BMC Public Health; 2017 Jun; 17(1):599. PubMed ID: 28651574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus (HPV) vaccine coverage achievements in low and middle-income countries 2007-2016.
    Gallagher KE; Howard N; Kabakama S; Mounier-Jack S; Burchett HED; LaMontagne DS; Watson-Jones D
    Papillomavirus Res; 2017 Dec; 4():72-78. PubMed ID: 29179873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between HPV vaccination among women and their 11-14-year-old children.
    Kornides M; Head KJ; Feemster K; Zimet GD; Panozzo CA
    Hum Vaccin Immunother; 2019; 15(7-8):1824-1830. PubMed ID: 31295048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical cancer prevention in Indonesia: An updated clinical impact, cost-effectiveness and budget impact analysis.
    Setiawan D; Andrijono ; Hadinegoro SR; Meyta H; Sitohang RV; Tandy G; Perwitasari DA; Postma MJ
    PLoS One; 2020; 15(3):e0230359. PubMed ID: 32203527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [HPV vaccination in Germany Low vaccination rates endanger prevention goals].
    MMW Fortschr Med; 2009 Dec; 151(51-52):44-5. PubMed ID: 20088323
    [No Abstract]   [Full Text] [Related]  

  • 11. HPV vaccination in Japan: what is happening in Japan?
    Ikeda S; Ueda Y; Yagi A; Matsuzaki S; Kobayashi E; Kimura T; Miyagi E; Sekine M; Enomoto T; Kudoh K
    Expert Rev Vaccines; 2019 Apr; 18(4):323-325. PubMed ID: 30768373
    [No Abstract]   [Full Text] [Related]  

  • 12. Time to resume active recommendation of the HPV vaccine in Japan.
    Tanaka Y
    Lancet Oncol; 2020 Dec; 21(12):1552-1553. PubMed ID: 33271087
    [No Abstract]   [Full Text] [Related]  

  • 13. Beyond resumption of the Japanese Government's recommendation of the HPV vaccine.
    Ueda Y; Yagi A; Ikeda S; Enomoto T; Kimura T
    Lancet Oncol; 2018 Dec; 19(12):1563-1564. PubMed ID: 30507414
    [No Abstract]   [Full Text] [Related]  

  • 14. HPV vaccination: a decade on.
    Lancet; 2016 Jul; 388(10043):438. PubMed ID: 27507742
    [No Abstract]   [Full Text] [Related]  

  • 15. HPV vaccinations: a Middle Eastern and north African dilemma.
    Baghi HB; Yousefi B; Oskouee MA; Aghazadeh M
    Lancet Infect Dis; 2017 Jan; 17(1):18-19. PubMed ID: 27998560
    [No Abstract]   [Full Text] [Related]  

  • 16. Playing games with girls' health: why it is too soon to mandate the HPV vaccine for pre-teen girls as a prerequisite to school entry.
    Gendel JE
    Seton Hall Law Rev; 2009; 39(1):265-90. PubMed ID: 19288617
    [No Abstract]   [Full Text] [Related]  

  • 17. Realities of alternative HPV vaccination schedules.
    Stanley M
    Salud Publica Mex; 2018; 60(6):617-620. PubMed ID: 30699265
    [No Abstract]   [Full Text] [Related]  

  • 18. HPV vaccine acceptance and hesitancy - lessons learned during 8 years of regional HPV prophylaxis program in Wroclaw, Poland.
    Ludwikowska KM; Biela M; Szenborn L
    Eur J Cancer Prev; 2020 Jul; 29(4):346-349. PubMed ID: 31770346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stopping the HPV vaccine crisis in Japan: Quantifying the benefits and risks of HPV vaccination in quality-adjusted life-years for appropriate decision-making.
    Kitano T
    J Infect Chemother; 2020 Mar; 26(3):225-230. PubMed ID: 31607433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPV vaccination in Italy: perspectives after 1-year experience.
    Icardi G
    J Prev Med Hyg; 2008 Dec; 49(4):125-8. PubMed ID: 19350958
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.